Sanofi (EPA:SAN)
France flag France · Delayed Price · Currency is EUR
80.98
+0.35 (0.43%)
Nov 3, 2026, 5:39 PM CET

Sanofi Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4,1787,8135,5605,4008,3716,223
Depreciation & Amortization
3,6853,2573,1113,2473,0533,001
Other Amortization
11211210511997119
Loss (Gain) From Sale of Assets
-79-79-298-103-470-357
Asset Writedown & Restructuring Costs
2,3092,3093691,062-42231
Loss (Gain) on Equity Investments
29029082293-45-15
Stock-Based Compensation
313313278260234244
Other Operating Activities
-684-5,287-43-1,456-879-389
Change in Accounts Receivable
-1,202-1,202-28-472-500185
Change in Inventory
-39-39-477-866-918-357
Change in Accounts Payable
398398789258340451
Change in Other Net Operating Assets
2,6382,638-8991,4932841,130
Operating Cash Flow
11,95910,7509,08110,25810,52610,522
Operating Cash Flow Growth
7.58%18.38%-11.47%-2.55%0.04%41.84%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,986-1,762-1,733-1,619-1,529-1,478
Sale of Property, Plant & Equipment
8158471,4618071,340676
Cash Acquisitions
-9,394-9,394-1,901-2,535-987-5,594
Sale (Purchase) of Intangibles
-1,035-1,776-1,462-1,287-574-565
Investment in Securities
-684-684-623-92-353-269
Other Investing Activities
6,96910,322-149-1,47428-68
Investing Cash Flow
-5,315-2,447-4,407-6,200-2,075-7,298

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--59751216-
Long-Term Debt Issued
-5,559-481,549-
Total Debt Issued
5,5595,559597991,765-
Short-Term Debt Repaid
--1,100----414
Long-Term Debt Repaid
--2,955-953-3,936-2,998-2,390
Lease Payments
-333-333-282-253-280-149
Total Debt Repaid
-4,055-4,055-953-3,936-2,998-2,804
Net Debt Issued (Repaid)
1,5041,504-894-3,137-1,233-2,804
Issuance of Common Stock
177177187195188186
Repurchase of Common Stock
-5,030-5,030-302-593-497-382
Common Dividends Paid
-9,695-4,772-4,704-4,454-4,168-4,008
Other Financing Activities
3,429-86-50-63-111-48
Financing Cash Flow
-9,615-8,207-5,763-8,052-5,821-7,056

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
25-47-13-32815
Miscellaneous Cash Flow Adjustments
-167-167---
Net Cash Flow
-2,946216-1,269-4,0262,638-3,817

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
9,9738,9887,3488,6398,9979,044
Free Cash Flow Growth
6.29%22.32%-14.94%-3.98%-0.52%46.72%
Free Cash Flow Margin
19.56%19.24%16.59%21.02%22.32%23.09%
Free Cash Flow Per Share
8.257.335.856.887.167.19
Levered Free Cash Flow
8,08216,643-4,9447,1728,5147,336
Unlevered Free Cash Flow
8,47616,975-4,5437,5408,7657,562
Free Cash Flow After Leases
9,6408,6557,0668,3868,7178,895

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
485485587559380334
Cash Income Tax Paid
2,8852,8853,2912,6232,4521,280
Change in Working Capital
1,7951,795-615413-7941,409